April 18, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
News Search

The results of your word search

Headline News

Eisai Launches Programs to Help Eliminate Lymphatic Filariasis By 2020 (Jan 31, 2012)

Eisai and Apollo Hospitals, HelpAge India to Improve Access to Medicines in India (Jan 18, 2011)

Eisai's New Sales Subsidiary in Canada (May 11, 2010)

Eisai to Sell Catheter Subsidiary to Terumo (June 19, 2008)

Takeda, Eisai Log Recurring Profit Falls in FY '07 (May 14, 2008)

Eisai Launches Sales Support Firm for Pharm. Machines in China (May 7, 2008)

M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503 (Mar 12, 2008)

Eisai Aiming to Achieve 1.5-T.-Yen Sales by FY 2016 (Mar 4, 2008)

Eisai to Buy Out U.S. Drug Maker MGI Pharma (Dec 10, 2007)

Eisai to Sell Kissei's Insulin Secretagogue in China (Sept 28, 2007)

more...
Press Release News

Eisai CEO Haruo Naito Appointed Knight Commander of British Empire (Apr 15, 2014)

Eisai Launches New Energy Drink "Joma" (Apr 7, 2014)

Notice Concerning Voluntary Adoption of International Financial Reporting Standards (IFRS) (Mar 25, 2014)

Eisai Enters Collaboration with Liverpool School of Tropical Medicine and University of Liverpool to Discover Novel Anti-Wolbachia Targeted Anti-Filarial Drugs (Mar 20, 2014)

Eisai Announces Launch of Pariet(R) Triple Formulation Combination Packs Rabecure(R) 400 and 800 and Rabefine(R), for Primary and Secondary H.Pyloei Eradication Respectively, in Japan (Feb 13, 2014)

Phase III Trial Shows Lenvatinib Meets Primary Endpoint of Progression Free Survival Benefit in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer (Feb 3, 2014)

Eisai Announces Launch of Vascular Embolization Device DC Bead(R) in Japan (Feb 3, 2014)

Eisai Announces Launch of New "Crystal Veil Mask Bokin 24 Mint" Face Mask Spray Containing Long-acting Antimicrobial Agent Etak (Jan 22, 2014)

Eisai Announces Launch of Antiepileptic Drug Fycompa in U.S. (Jan 6, 2014)

Eisai to Present New Research on Halaven (Eribulin) at 36th Annual San Antonio Breast Cancer Symposium (Dec 5, 2013)

more...
 
CSR Report Download
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)